Upfront nilotinib therapy among patients with chronic myeloid leukemia in chronic phase


Eskazan A. E.

EXPERT OPINION ON PHARMACOTHERAPY, vol.18, no.3, pp.325-326, 2017 (SCI-Expanded) identifier identifier identifier